For patients with hypercholesterolemic bladder cancer, serum ox-LDL can bind to CD36 and activate the JAK2-pSTAT3 pathway, thereby promoting the cancer stemness of bladder cancer, increasing cancer cell proliferation, and inducing epithelial-mesenchymal transition in vitro. The gene discussed is JAK2; the disease is urinary bladder cancer.